info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Circulating Tumor Cell Companies

Circulating tumor cell (CTC) companies specialize in the isolation, detection, and analysis of cancer cells that have entered the bloodstream, with the goal of improving cancer diagnosis, treatment monitoring, and research. CTCs provide valuable insights into a patient's cancer status and can help guide treatment decisions.

Circulating Tumor Cell Key Companies*Disclaimer: List of key companies in no particular orderLatest Circulating tumor cell (CTC) Companies Update



  • September 2023: The Portrait commerce; Flex CTC assay has been released by ANGLE plc, a major global provider of breakthrough circulating tumor cell (CTC) diagnostic products for the research and diagnostic oncology industry. The test is performed by a specialized team with over 10 years of expertise in CTC analysis and is offered as a service from ANGLE's Onc-ADaPT™ GCP-compliant facilities. Portrait Flex is used to count and characterize CTCs that have been caught and harvested utilizing ANGLE's Parsortix® technology.




  • July 2023: To identify the expression of the Delta-Like Ligand 3 (DLL3) protein in tumor cells circulating in the blood, Menarini Silicon Biosystems (MSB), a leader in liquid biopsy and single cell technologies, has released their new CELLSEARCH CTC lab service in the month of July 2023. The majority of tumors that display this biomarker are particularly hard to cure. The new MSB lab service paves the way for the creation of further non-invasive tests that take use of biomarkers' prognostic and predictive significance in healthcare settings with significant unmet needs.




  • April 2023: Epic Sciences, Inc., a privately held diagnostics firm, has raised a total of $67 million in the previous twelve months after completing a $24 million Series G fundraising in April 2023. This follows a $43 million Series F investment. In order to market the three tests that make up DefineMBC and deliver a full blood-based biopsy result for patients with metastatic breast cancer, the business has raised further private funding. Investors such as Blue Ox Healthcare Partners, Domain Ventures, and Labcorp joined Deerfield Management and Arsenal Capital Partners in leading the investment.


List of Circulating tumor cell (CTC) Key companies in the market

  • STEMCELL Technologies, Inc.

  • QIAGEN

  • Sysmex Corporation

  • Bio-Techne Corporation

  • Menarini Silicon Biosystems

  • AVIVA Biosciences

  • ScreenCell

  • Fluxion Biosciences, Inc.

  • Creativ MicroTech

  • Biolidics Limited

  • IVDiagnostics

  • Inc Ikonisys Inc.

  • Canopus Bioscience Ltd

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.